T37.2X5SBillable
Adverse effect of antimalarials and drugs acting on other blood protozoa, sequela
Short description: Advrs effect of antimalari/drugs acting on bld protzoa, sqla
- Chapter
- 19. Injury, poisoning and certain other consequences of external causes
- Category
- T37
- Effective date
- October 1, 2026
Related codes in category T37
T37Other systemic anti-infectives and antiparasiticsT37.0SulfonamidesT37.0XSulfonamidesT37.0X1Poisoning by sulfonamides, accidental (unintentional)T37.0X1APoisoning by sulfonamides, accidental (unintentional), initYesT37.0X1DPoisoning by sulfonamides, accidental (unintentional), subsYesT37.0X1SPoisoning by sulfonamides, accidental, sequelaYesT37.0X2Poisoning by sulfonamides, intentional self-harmT37.0X2APoisoning by sulfonamides, intentional self-harm, initYesT37.0X2DPoisoning by sulfonamides, intentional self-harm, subsYesT37.0X2SPoisoning by sulfonamides, intentional self-harm, sequelaYesT37.0X3Poisoning by sulfonamides, assault
Frequently asked questions
What is ICD-10 code T37.2X5S?
T37.2X5S is an ICD-10-CM diagnosis code for Adverse effect of antimalarials and drugs acting on other blood protozoa, sequela.
Is T37.2X5S a billable code?
Yes. T37.2X5S is billable and specific enough to be used on a claim.
What ICD-10-CM chapter is T37.2X5S in?
T37.2X5S falls under Chapter 19: Injury, poisoning and certain other consequences of external causes.
When did T37.2X5S become effective?
T37.2X5S has been effective since October 1, 2026, per the CMS/CDC ICD-10-CM annual release.
What other codes are related to T37.2X5S?
T37.2X5S belongs to category T37, which includes 12 other codes — see the related codes list on this page.
ICD-10-CM data maintained by CDC/CMS (public domain). Always verify codes with authoritative sources before making coding or billing decisions.